BioCentury
ARTICLE | Finance

Ebb & Flow

March 30, 2009 7:00 AM UTC

With Genentech's takeout now complete, industry watchers will be looking for when the biotech's executives will head for the exits. Based on the structure of the bonus payouts in the employee retention plan, a number of the company's senior managers have at least seven-figure reasons to stay around another 12 months when the other half of their retention bonus comes due.

The retention clock began ticking last Thursday when Roche (SIX:ROG) consummated its tender offer for the rest of Genentech it did not already own...